U.S.: FTC, animal health co reach agreement on distribution exclusivity deals
IDEXX Laboratories Inc has signed a Consent Agreement with the Federal Trade Commission to settle an investigation into whether the diagnostics and information technology solutions company had hampered competition. The company specializes in animal health as well as water and milk supply quality. Under terms of the agreement, IDEXX can no longer have exclusive distribution contracts with three veterinary companies at once. The three companies named are MWI Veterinary Supply, Inc., Butler Schein Animal Health and Webster Veterinary. The agreement says that IDEXX can maintain those exclusivity agreements with two at once, however. IDEXX has not admitted to any legal misdoings, and its CEO and chairman Jonathan Ayers said in a statement that the agreement is a “milestone” in resolving the investigation.
Full Content: Daily Markets
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DirecTV Urges Second Circuit to Revive Antitrust Lawsuit Against Nexstar
Dec 9, 2024 by
CPI
Omnicom and Interpublic Unite in $13.25B Deal: Big Tech Competition Heats Up
Dec 9, 2024 by
CPI
Federal Ruling Highlights DOJ’s Push Against Algorithmic Collusion in Antitrust Cases
Dec 9, 2024 by
CPI
Judge’s Decision on Kroger-Albertsons Merger Expected Soon
Dec 9, 2024 by
CPI
Supreme Court Urged to Resolve Legal Standoff Over Amazon and Flipkart Investigation
Dec 9, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Moats & Entrenchment
Nov 29, 2024 by
CPI
Assessing the Potential for Antitrust Moats and Trenches in the Generative AI Industry
Nov 29, 2024 by
Allison Holt, Sushrut Jain & Ashley Zhou
How SEP Hold-up Can Lead to Entrenchment
Nov 29, 2024 by
Jay Jurata, Elena Kamenir & Christie Boyden
The Role of Moats in Unlocking Economic Growth
Nov 29, 2024 by
CPI
Overcoming Moats and Entrenchment: Disruptive Innovation in Generative AI May Be More Successful than Regulation
Nov 29, 2024 by
Simon Chisholm & Charlie Whitehead